comparemela.com
  1. Home
  2. Live Updates
  3. Avi Katav - Breaking News

Avi Katav News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chemomab Therapeutics Presents Data Reinforcing the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2023

/PRNewswire/ Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare.

Barbara lindheimWadi morRaanan greenmanRifaat safadiAvi katavJohn lawlerHomer leviDouglas thorburnChris cirilloIrina kofflerMatthew frankelShelia sherlockTom snirChristopher bowlusIlan vakninMassimo pinzani

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.